MedTrace Logo

Feasibility of EnChroma Use in the Emergency Department Setting

NCT04021914 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2023-09-18

Study results available
· View outcomes & findings →

Summary

This study addresses whether the use of EnChroma products are feasible for use in the emergency department by color vision deficient providers.

Conditions

  • Color Vision Defects

Interventions

DEVICE

EnChroma glasses

Each participant will be provided EnChroma products to use indoors over the course of two weeks in the emergency department, educational settings, and in their personal life. They will be encouraged to wear the glasses for at least 10 hours over 1-2 weeks prior to wearing them in a clinical setting to adjust to their use, and for 10 minutes before beginning patient care as per manufacturer instructions. They will be encouraged to take specific note of clinical scenarios that require the use of color vision (e.g., - rashes, tympanic membrane erythema, stool guaiac testing, etc.).

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Jeffrey Siegelman, MD · Emory Univer

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-14
Primary Completion
2023-03-15
Completion
2023-03-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04021914 on ClinicalTrials.gov